Abstract
Introduction
Ocular infections such as conjunctivitis and bacterial keratitis are acute or chronic infections that are often caused by the improper care and cleaning of contact lenses or trauma to the ocular surface, and may result in conjunctival scarring or severe keratitis, ultimately leading to loss of vision [1, 2] . Although antibiotic therapy has improved the rates of clinical remission in patients suffering from ocular surface infection [3] , microbial resistance to antibiotics continues to be a serious problem that is on the rise and needs to be overcome.
Staphylococcus aureus and coagulase-negative staphylococci (CNS), including Staphylococcus epidermidis, are important pathogens that reportedly lead to ocular surface infection [1] . MRSA is known to cause severe ocular surface infections that can lead to loss of vision, and our and others' previous studies have reported that methicillin-resistant S. aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MR-CNS) are highly resistant to various antibiotics [2, [4] [5] [6] [7] . It has recently been reported that Corynebacterium can cause ocular surface infection, even though it is considered to be a non-pathogenic organism [8] [9] [10] [11] [12] , and fluoroquinolone-resistant Corynebacterium has become a growing issue of concern [9, 13] .
Our and others' studies have reported that vancomycin ophthalmic ointment 1% is effective for the treatment of intractable ocular MRSA and methicillin-resistant S. epidermidis (MRSE) infections [14, 15] . However, it is widely known that the misuse, overuse, or prophylactic use of these new antibiotics can result in antimicrobial resistance, which presents a serious problem [16] [17] [18] . In fact, there are now confirmed reports of a resistance to treatment with vancomycin [19] . Thus, we postulate that the antibiotic susceptibility patterns of organisms on the ocular surface, i.e., MRSA, MRSE, and fluoroquinolone-resistant Corynebacterium, in specific, might change over numerous years (e.g., 10 years or more). However, there are currently few reports regarding the trend of antimicrobial resistance over a 10-year time period for the treatment of acute bacterial ocular infections [20] .
The purpose of this present study was to retrospectively identify epidemiological trends of infection on the ocular surface, and investigate antibiotics compared with 10-years previous.
Materials and methods
This retrospective study was approved by the Kyoto Ethics Review Board (ERB), Kyoto, Japan (ERB Approval: #1604), and written informed consent was obtained from all subjects in accordance with the tenets set forth in the Declaration of Helsinki.
This single-center study involved 115 eyes of 103 consecutive Japanese outpatients (50 males and 53 females; mean age: 50. 4 At the onset of ocular infection, bacterial isolates were collected from the conjunctival sac by use of a sterile cotton swab (Seed Swab No. 2; Eiken Chemical Co., Ltd., Tokyo, Japan) with the utmost care not to contaminate ocular samples with organisms on skin. The samples were inoculated in aerobic culture, and then transported to the research laboratory on the day of collection. The bacteria that grew on the aerobic culture plates were identified by gram staining and coagulase testing. Methicillin resistance was determined by anti-oxacillin. The susceptibility for clinical isolates to levofloxacin (LVFX), cefmenoxime (CMX), chloramphenicol (CP), erythromycin (EM), vancomycin (VCM), and arbekacin (ABK) was measured via the disc susceptibility method for MRSA, MR-CNS, and Corynebacterium, because these are the antimicrobials that are mainly available in Japan. Briefly, a bacteria isolate was seeded on the agar plate with antibiotics (KB disc 1 , Eiken Chemical Co., Ltd., Tokyo, Japan). After overnight culture, the area of inhibited bacterial growth was assessed according to the specific organism as previously reported [21, 22] . There were no changes in susceptibility testing compared with 10-years previous. Two eyes with MR-CNS and 5 eyes with Corynebacterium in 2014-2015 that did not undergo susceptibility testing were excluded in this analysis.
Strains of bacteria that were repeatedly obtained from the same eye were counted as the same strain. However, in cases with a different antibiotic resistance pattern, the strains of bacteria were counted as a different strain.
Statistical analysis
Statistical analysis was performed using JMP 
Results
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Bacterial , respectively], while 10-years later, the prevalence of MRSA in S. aureus infections had decreased to 22% (n = 7) and MR-CNS in CNS had decreased to 25% (n = 19), thus illustrating significant reduction rates compared with 10-years previous (P < 0.05 and P < 0.05, respectively) (Fig 2A and 2B) . All MRSA and MR-CNS cases were susceptible to VCM and ABK, thus suggesting that the susceptibility of MRSA and MR-CNS to antibiotics had not changed compared with 10-years previous (Fig 3A) . In regard to fluoroquinolone-resistant Corynebacterium, the susceptibility to antibiotics in 2014-2015 was nearly similar to that of 2004-2005, yet the susceptibility to EM had increased from 13% to 28%. The susceptibility to CMX was equivalent to that of to ABK and VCM during both periods, however, the susceptibility to CP of fluoroquinolone-resistant Corynebacterium was relatively low compared to that of MRSA and MR-CNS (Fig 3B) . The trend of antibiotics resistance compared with 10-years previous in Japan
Discussion
In this retrospective study, our findings revealed that the prevalence of MRSA and MR-CNS infections in Japanese subjects with ocular infections has significantly decreased compared with 10-years previous, yet the prevalence of fluoroquinolone-resistant Corynebacterium infection has remained the same. In addition, our findings showed no change in It is widely known that antimicrobial resistance is rising to high levels globally due to the misuse and overuse of antibiotics, and that the resistance to multiple antibiotics is on the increase. Numerous studies have reported that MRSA contributes to the pathology of various eye diseases, such as refractory corneal ulcer, conjunctivitis, endophthalmitis, orbital cellulitis, and blebitis post glaucoma surgery [2, 7, [23] [24] [25] [26] [27] [28] [29] [30] [31] . We previously reported that subject exposure to medical treatment environments (i.e., hospital facilities and private clinics) accelerates the risk factor of MRSA colonization and MRSA infections [32] , and that MRSA keratitis post refractive surgery is one of the severe complications [2, 33, 34] . A previous study reported that there is an increased tendency in the prevalence of MRSA conjunctivitis in elderly people aged 65 years or older, and that it accounted for 15.3% in 1996, 58.3% in 1997, and 69.8% in 1998 [35] . However, other recent studies have reported that the incidence of MRSA reached its peak in the late 1990s, and has actually been on the decline since the late 2000s [36] [37] [38] . The findings in this present study on acute ocular infection revealed that the prevalence of MRSA or MR-CNS infections has significantly decreased compared with 10-years previous, which is similar to the findings in recent reports in other fields of medicine. However, compared to the previous report in 2012 by Hsiao and colleagues [39] , which showed that the prevalence of MRSA in ocular S. aureus infections was 53%, the prevalence of MRSA in our present study was 22%, and thus relatively low. This might be due to the decline of healthcare-associated MRSA (HA-MRSA) that results from the proper use of the antibiotics and strict compliance with standard precautions [40] , such as practiced in our institute. However, the distinction between community-acquired MRSA (CA-MRSA) and HA-MRSA was not considered or investigated in this present study.
Increased microbial resistance to fluoroquinolones has been widely reported [13, 41, 42] . The findings of Chang and associates [41] demonstrated an increase in the resistance rates to fourth-generation fluoroquinolones for both methicillin-susceptible S. aureus and MRSA. Moreover, it has been recently reported that MRSA has acquired a resistance to VCM, and that VCM-resistant S. aureus strains are on the increase in certain countries [43, 44] . These findings are possible correlated with the increasing popularity of VCM eye drops or ointment since their introduction. Contrary to what we had expected, the findings in this present study demonstrated no change in the resistance level of MRSA or MR-CNS to LVFX, and that they were both susceptible to ABK and VCM, thus suggesting that the trend of MRSA and MR-CNS resistance to various antibiotics during the 10-year time period was stable in the field of ophthalmology, similar to the findings in other fields of medicine. It has been reported that MRSA and MR-CNS maintained a reasonable level of sensitivity to CP, a commonly used empirical topical antibiotic eye drop [4] . Interestingly, CP has higher susceptibility than LVFX and CMX, thus suggesting that it may be selected as a 'first choice' treatment for MRSA and MR-CNS, as previously reported [4] .
Interestingly, 60% of the Corynebacterium isolates in this present study had acquired resistance to LVFX in [2004] [2005] . It has been reported that Corynebacterium is a non-pathogenic organism. However, recent clinical findings have shown the existence of fluoroquinoloneresistant Corynebacterium in ocular-surface infections [9, [11] [12] [13] , and in Japan, fluoroquinolone eye drops are commonly used as a 'first choice' treatment for ocular infections. Thus, we had feared an increase in the resistance to fluoroquinolones. Investigation of the trend of the prevalence of fluoroquinolone-resistant Corynebacterium revealed that half of Corynebacterium is resistant to fluoroquinolones, contrary to the decline of the prevalence of MRSA and MR-CNS, even though the prevalence of resistant Corynebacterium had not increased compared with 10-years previous. This finding suggests that a cautionary use of fluoroquinolone eye drops should maybe be followed in order to reduce the prevalence of fluoroquinoloneresistant Corynebacterium. The susceptibility analysis of the antibiotics showed that fluoroquinolone-resistant Corynebacterium had high sensitivity (i.e., more than 90%) to CMX, thus suggesting that CMX might be an effective alternative treatment in cases of conjunctivitis resistance to LVFX.
It should be noted that this study did include some limitations. First, it was a retrospective study, and some of the data without susceptibility testing were excluded. Second, we focused on only MRSA, MR-CNS, and fluoroquinolone-resistant Corynebacterium in this study, because approximately 80% of the isolated bacteria were Staphylococcus, CNS, and Corynebacterium. Thus, further study is necessary to investigate the drug susceptibility for all isolates of ocular infections. Third, CNS and Corynebacterium may not have been the cause of some of the infections, as their pathogenic potential is significantly less than that of S. aureus. However, the ocular samples were collected with utmost care in order to not contaminate those samples with organisms on skin, and we think that this present study showed resistant bacteria of only ocular surface infections.
In conclusion, our findings demonstrated that MRSA, MR-CNS, and fluoroquinoloneresistant Corynebacterium had no significant increase of resistance to various antibiotics compared with 10-years previous, while 50% in Corynebacterium infections were still resistant to fluoroquinolones. Moreover, we found that in eye-drop treatments, MRSA and MR-CNS organisms were susceptible to CP and that the fluoroquinolone-resistant Corynebacterium organism was susceptible to CMX. We hope that our findings in this present study will prove beneficial to empirical antibacterial treatment.
